APA

Druzhyna N., Szczesny B., Olah G., Módis K., Asimakopoulou A., Pavlidou A., Szoleczky P., Gerö D., Yanagi K., Törö G., López-García I., Myrianthopoulos V., Mikros E., Zatarain J. R., Chao C., Papapetropoulos A., Hellmich M. R. & Szabo C. (20171220). Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer. : Pharmacological research.

Chicago

Druzhyna Nadiya, Szczesny Bartosz, Olah Gabor, Módis Katalin, Asimakopoulou Antonia, Pavlidou Athanasia, Szoleczky Petra, Gerö Domokos, Yanagi Kazunori, Törö Gabor, López-García Isabel, Myrianthopoulos Vassilios, Mikros Emmanuel, Zatarain John R, Chao Celia, Papapetropoulos Andreas, Hellmich Mark R and Szabo Csaba. 20171220. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer. : Pharmacological research.

Harvard

Druzhyna N., Szczesny B., Olah G., Módis K., Asimakopoulou A., Pavlidou A., Szoleczky P., Gerö D., Yanagi K., Törö G., López-García I., Myrianthopoulos V., Mikros E., Zatarain J. R., Chao C., Papapetropoulos A., Hellmich M. R. and Szabo C. (20171220). Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer. : Pharmacological research.

MLA

Druzhyna Nadiya, Szczesny Bartosz, Olah Gabor, Módis Katalin, Asimakopoulou Antonia, Pavlidou Athanasia, Szoleczky Petra, Gerö Domokos, Yanagi Kazunori, Törö Gabor, López-García Isabel, Myrianthopoulos Vassilios, Mikros Emmanuel, Zatarain John R, Chao Celia, Papapetropoulos Andreas, Hellmich Mark R and Szabo Csaba. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer. : Pharmacological research. 20171220.